ARCHIVES

GSK’s Votrient Approved For Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results

October 24, 1986

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

FDA Offers Grants For Conferences

May 1, 1987

In Brief: GSA Sitting On Breast Cancer Tapes; Creech, Owens Names President-Elect Of AACR, ASCO

May 27, 1977

Toxicology Program Board To Review Nine Substances.

January 14, 2000